News

Contents online PDF of this issue Subscribe by email This last slim issue of HTB this year includes final reports from recent conferences, including HIVR4P and Glasgow 2018. We also report that doravirine and the FDC with TDF and 3TC …

Resources with Treatment Action Campaign on modern ART in Africa…

Integrase inhibitors and pregnancy, new approaches to PrEP, why U=U is not for breastfeeding and more…

21–25 October 2018, Madrid Introduction The Research for Prevention (R4P) conferences are held every two years to focus on vaccines, PrEP, microbicides, treatment as prevention and other biomedical prevention approaches. This year the meeting was held in Madrid and attended …

Contents online PDF of this issue Subscribe by email This issue of HTB includes diverse news and reports that cover a surprising and disturbingly wide ground. Even though this was expected to be a quiet month, there is a lot …

PrEP in Scotland is a the second edition of a booklet produced by the PrEP coordination group in Scotland. PrEP In Scotland (2nd edition) July 2018 – download/view PDF file More information about PrEP in Scotland can be found at prep.scot …

Latest HTB online. Generic PrEP in England, UK surveillance data, AIDS 2018 reports and more…

i-Base have produced new resources to help raise the profile of U=U in UK clinics. A3 colour posters A6 double-sided post cards U=U factsheet leaflets: Q&A format to explain U=U in more detail. This leaflet is formatted to print in …

Further reports from AIDS 2018: global health, HPV, PrEP, cure, diagnostics + more…

PARTNER2, GEMINI, dolutegravir and pregnancy, DRV/r once-daily, cure research and more

Trial Tracker is a new i-Base resource that publishes routinely updated tables on the web. This is freely available via i-Base’s Google Docs. Op ART trial tracker i-Base’s Op ART trial tracker follows research on optimised antiretroviral treatment for low- …

23 – 27 July 2018, Amsterdam Early reports i-Base reports, including from the HIV paediatric workshop held before AIDS 2018, will be added to the list of articles below. WHO recommends dolutegravir widely but women’s access will depend on contraception …

Contents online PDF of this issue Subscribe by email This HTB leads with a special report by Polly Clayden into the response to the recent safety alerts concerning dolutegravir (DTG) and its use preconception and a related article on balancing …

Simon Collins, HIV i-Base This is the second year that i-Base has produced the HIV pipeline review as part of our Fit for Purpose report on HIV treatment optimisation. Two versions will be available: 1. The full version reports key …

Contents online PDF of this issue Subscribe by email This issue of HTB starts with a treatment alert stating that cobicistat boosted darunavir is contraindicated in pregnant women. This is based on significantly reduced plasma levels of darunavir and cobicistat …

Darunavir and heart disease, a controversial review of PrEP, albuvirtide approved in China…

Contents online PDF of this issue Subscribe by email This issue of HTB leads with worrying reports of a potential signal of neural tube defects in four women taking dolutegravir at the time of conception. Importantly, there is no signal …

4th BHIVA/BASHH conference in Edinburgh… access to services, new guidelines, standards of care, WeLoveKissing…

Third set of reports from CROI: pregnancy, adolescent care, drug interactions and side effects…

CROI reports: ibalizumab, pregnancy and review cure studies